FIBRIVEN Trademark

Trademark Overview

On Friday, September 25, 2009, a trademark application was filed for FIBRIVEN with the United States Patent and Trademark Office. The USPTO has given the FIBRIVEN trademark a serial number of 79074515. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, September 25, 2019. This trademark is owned by Novo Nordisk Health Care AG. The FIBRIVEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products against haemophilia
fibriven

General Information

Serial Number79074515
Word MarkFIBRIVEN
Filing DateFriday, September 25, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, September 25, 2019
Registration Number3870284
Registration DateTuesday, November 2, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2010

Trademark Statements

Goods and ServicesPharmaceutical products against haemophilia
Translation of Words in MarkThe wording "FIBRIVEN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 9, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk Health Care AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Friday, April 17, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, April 17, 2020DEATH OF INTERNATIONAL REGISTRATION
Friday, March 16, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, February 21, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, February 20, 2018INVALIDATION PROCESSED
Friday, February 9, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 9, 2017CANCELLED SECTION 71
Thursday, February 5, 2015CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, January 30, 2015CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, November 27, 2014CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, March 5, 2011FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, February 14, 2011FINAL DISPOSITION NOTICE SENT TO IB
Monday, February 14, 2011FINAL DISPOSITION PROCESSED
Wednesday, February 2, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 2, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, August 17, 2010PUBLISHED FOR OPPOSITION
Wednesday, July 28, 2010NOTICE OF PUBLICATION
Thursday, July 15, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 15, 2010ASSIGNED TO LIE
Tuesday, June 29, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 22, 2010REFUSAL PROCESSED BY IB
Tuesday, December 29, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 29, 2009REFUSAL PROCESSED BY MPU
Thursday, December 24, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 23, 2009SUSPENSION LETTER WRITTEN
Wednesday, December 23, 2009ASSIGNED TO EXAMINER
Friday, November 27, 2009APPLICATION FILING RECEIPT MAILED
Monday, November 23, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 20, 2009LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, November 19, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

fibriven haemophilia against products pharmaceutical